• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Industrials·RCMT
Share

RCM Technologies, Inc. Stocks

$ 27.39Last Updated 15.07.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 194.77M

$ 27.39
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

RCM Technologies, Inc. delivers business and technology-focused solutions across the United States, Canada, Puerto Rico, and Serbia. The company organizes its operations into three distinct divisions: Engineering, Specialty Health Care, and Life Sciences and Information Technology. The Engineering division provides diverse services, including project management, design, analytical work, engineer-procure-construct (EPC) services, configuration management, hardware/software validation and verification, quality assurance, technical documentation, manufacturing process optimization, and integrated 3D/BIM design. Within its Specialty Health Care unit, RCM offers both temporary and permanent staffing, executive recruitment, and placement services. These cater to various healthcare domains such as allied health and therapy, correctional healthcare, health information management, nursing, physician and advanced practice roles, school services, and telepractice. The Life Sciences and Information Technology segment concentrates on supplying comprehensive enterprise business solutions, application services, robust infrastructure solutions, strategies for competitive advantage, specialized life sciences offerings, and tailored solutions for other specific vertical markets. RCM Technologies serves a broad spectrum of industries, including aerospace and defense, energy, financial services, healthcare, life sciences, manufacturing and distribution, and technology. Additionally, their clientele extends to educational institutions and governmental bodies. Founded in 1971, RCM Technologies, Inc. is headquartered in Pennsauken, New Jersey.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of RCMT is 37.0 and suggests 35.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

17.07.2026 10:35

Top Stories This Morning: SpaceX Cancels Starship Launch; Tech Stocks Under Pressure

17.07.2026 09:30

Berkshire Hathaway may have accelerated its share buyback. This was indicated in Buffett's documents

17.07.2026 08:30

Lilly to Acquire Psychedelic Drug Developer for $3.8 Billion. Are There Any Prospects?

17.07.2026 07:30

Netflix is expecting a slowdown in revenue growth for the second consecutive quarter. Its stock plummeted 8%.

17.07.2026 02:57

The release of Google's cutting-edge AI model has been delayed by months — Bloomberg. Shares fell

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026